Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-15 4:20 pm Purchase | 13D | 23ANDME HLDG CO ME | GSK plc GSK | 1,983,025 9.500% | 1,983,025 (New Position) | View |
| 2024-11-12 4:32 pm Purchase | 13G | GSK PLC SPONSORED ADR GSK | GSK plc GSK | 16,775,691 11.200% | 2,791,930 (+19.97%) | View |
| 2024-03-28 5:06 pm Unchanged | 13D | NKARTA INC NKTX | GSK plc GSK | 3,161,432 4.500% | 0 (Unchanged) | View |
| 2024-02-13 1:37 pm Purchase | 13G | GSK PLC SPONSORED ADR GSK | DODGE & COX | 102,084,740 5.800% | 6,254,900 (+6.53%) | View |
| 2024-02-09 4:18 pm Unchanged | 13D | 23ANDME HLDG CO ME | GSK plc GSK | 39,660,487 11.200% | 0 (Unchanged) | View |
| 2024-02-06 5:10 pm Purchase | 13G | CUREVAC N V CUREVAC N V IN CON CVAC | GSK plc GSK | 16,591,937 7.400% | 1,656,216 (+11.09%) | View |
| 2024-02-06 5:07 pm Purchase | 13G | Wave Life Sciences Ltd. WVE | GSK plc GSK | 13,983,761 11.500% | 3,300,000 (+30.89%) | View |
| 2024-01-19 4:20 pm Sale | 13D | HALEON PLC ADR HLN | GSK plc GSK | 385,320,110 4.200% | -352,812,612 (-47.80%) | View |
| 2023-10-10 4:07 pm Sale | 13D | HALEON PLC ADR HLN | GSK plc GSK | 738,132,722 8.000% | -270,000,000 (-26.78%) | View |
| 2023-09-11 4:37 pm Unchanged | 13D | HALEON PLC ADR HLN | GSK plc GSK | 1,008,132,722 10.900% | 0 (Unchanged) | View |
| 2023-07-19 6:29 pm Unchanged | 13D | BICYCLE THERAPEUTICS PLC BCYC | GSK plc GSK | 1,529,561 4.400% | 0 (Unchanged) | View |
| 2023-05-16 5:27 pm Sale | 13D | HALEON PLC ADR HLN | GSK plc GSK | 1,008,132,722 10.900% | -187,187,388 (-15.66%) | View |
| 2023-02-14 1:54 pm Purchase | 13G | GSK PLC SPONSORED ADR GSK | DODGE & COX | 95,829,840 5.500% | 95,829,840 (New Position) | View |
| 2023-02-06 4:06 pm Unchanged | 13G | CVRX INC CVRX | GSK plc GSK | 1,007,583 4.900% | 0 (Unchanged) | View |
| 2023-01-30 4:37 pm Purchase | 13G | Wave Life Sciences Ltd. WVE | GSK plc GSK | 10,683,761 10.950% | 10,683,761 (New Position) | View |
| 2023-01-20 4:08 pm Unchanged | 13D | 23ANDME HLDG CO ME | GSK plc GSK | 39,660,487 12.200% | 0 (Unchanged) | View |
| 2023-01-20 4:08 pm Unchanged | 13D | SPERO THERAPEUTICS INC SPRO | GSK plc GSK | 9,190,606 17.750% | 0 (Unchanged) | View |
| 2022-11-14 5:02 pm Purchase | 13D | SPERO THERAPEUTICS INC SPRO | GSK plc GSK | 9,190,606 19.990% | 7,450,000 (+428.01%) | View |
| 2022-11-04 4:08 pm Purchase | 13D | 23ANDME HLDG CO ME | GSK plc GSK | 39,660,487 13.200% | 39,660,487 (New Position) | View |
| 2022-09-20 4:12 pm Sale | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK plc GSK | 0 0.000% | -9,644,807 (Position Closed) | View |